First-Ever test: diabetes drug as nasal spray for spinal injury
NCT ID NCT07384052
Summary
This study is checking if insulin, a diabetes medication, is safe when given as a nasal spray to people with spinal cord injuries. It's a small, early-stage trial with 12 participants who will use the spray or a placebo at home for up to 24 days. The main goal is to see if this approach is safe and feasible before considering it as a future treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SPINAL CORD INJURY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
HealthPartners Neuroscience Center
RECRUITINGSaint Paul, Minnesota, 55130, United States
Contact Email: •••••@•••••
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.